Pecaut & CO. Invests $1.54 Million in BWX Technologies, Inc. $BWXT

Key Points

• Pecaut & CO. acquired a new $1.54 million stake in BWX Technologies during the second quarter, while institutional investors collectively own 94.39% of the company’s shares.
• Analysts maintain a generally positive outlook, with BWXT receiving a consensus “Moderate Buy” rating and an average price target of $227.20, despite some recent downgrades.
• BWX Technologies exceeded quarterly earnings expectations with $1.07 in EPS, while revenue rose 18% year over year to $901.62 million. The company also declared a quarterly dividend of $0.27 per share.

Pecaut & CO. bought a new position in BWX Technologies, Inc. (NYSE:BWXT - Free Report) during the second quarter, according to its most recent filing with the SEC. The firm bought 7,935 shares of the technology company's stock, valued at approximately $1,545,000.

Several other hedge funds have also bought and sold shares of the business. Oppenheimer Asset Management Inc. bought a new stake in BWX Technologies during the 2nd quarter valued at $1,233,000. Insight Wealth Strategies LLC bought a new position in shares of BWX Technologies in the second quarter valued at $5,949,000. Tema ETFs LLC lifted its stake in shares of BWX Technologies by 45.5% in the second quarter. Tema ETFs LLC now owns 81,179 shares of the technology company's stock valued at $15,801,000 after buying an additional 25,368 shares in the last quarter. Fulton Bank N.A. grew its holdings in shares of BWX Technologies by 3.6% during the second quarter. Fulton Bank N.A. now owns 6,186 shares of the technology company's stock valued at $1,204,000 after buying an additional 213 shares during the last quarter. Finally, Kastel Capital Advisors LLC acquired a new position in shares of BWX Technologies during the second quarter valued at about $212,000. Institutional investors and hedge funds own 94.39% of the company's stock.

Wall Street Analyst Weigh In

A number of equities research analysts recently weighed in on the stock. Weiss Ratings upgraded shares of BWX Technologies from a "hold (c+)" rating to a "buy (b-)" rating in a report on Wednesday. BTIG Research reiterated a "buy" rating and set a $235.00 price target on shares of BWX Technologies in a research note on Tuesday, August 4th. Truist Financial decreased their price objective on BWX Technologies from $212.00 to $202.00 and set a "hold" rating for the company in a report on Friday. Wall Street Zen downgraded BWX Technologies from a "buy" rating to a "hold" rating in a research note on Saturday, August 8th. Finally, Deutsche Bank Aktiengesellschaft upgraded BWX Technologies from a "hold" rating to a "buy" rating and raised their target price for the company from $205.00 to $255.00 in a report on Friday, May 15th. Two investment analysts have rated the stock with a Strong Buy rating, nine have given a Buy rating, three have issued a Hold rating and one has assigned a Sell rating to the company's stock. According to data from MarketBeat.com, BWX Technologies has a consensus rating of "Moderate Buy" and a consensus target price of $227.20.

BWX Technologies Trading Up 1.6%

Shares of BWXT stock opened at $173.14 on Friday. The company has a debt-to-equity ratio of 1.51, a quick ratio of 2.33 and a current ratio of 2.40. The company has a market capitalization of $15.86 billion, a price-to-earnings ratio of 44.86, a PEG ratio of 2.67 and a beta of 0.76. BWX Technologies, Inc. has a 52-week low of $157.10 and a 52-week high of $241.82. The company has a 50-day simple moving average of $183.41 and a two-hundred day simple moving average of $199.07.

BWX Technologies (NYSE:BWXT - Get Free Report) last posted its earnings results on Monday, August 3rd. The technology company reported $1.07 EPS for the quarter, topping the consensus estimate of $1.04 by $0.03. BWX Technologies had a net margin of 10.11% and a return on equity of 30.83%. The firm had revenue of $901.62 million for the quarter, compared to analysts' expectations of $902.41 million. During the same quarter last year, the firm earned $1.02 EPS. The company's quarterly revenue was up 18.0% compared to the same quarter last year. BWX Technologies has set its FY 2026 guidance at 4.700-4.800 EPS. Research analysts anticipate that BWX Technologies, Inc. will post 4.75 EPS for the current fiscal year.

BWX Technologies Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, September 4th. Shareholders of record on Tuesday, August 18th will be paid a $0.27 dividend. This represents a $1.08 dividend on an annualized basis and a yield of 0.6%. The ex-dividend date is Tuesday, August 18th. BWX Technologies's dividend payout ratio is 27.98%.

Insider Transactions at BWX Technologies

In other news, CEO Rex D. Geveden sold 10,000 shares of the firm's stock in a transaction on Wednesday, August 12th. The stock was sold at an average price of $172.50, for a total transaction of $1,725,000.00. Following the completion of the sale, the chief executive officer directly owned 192,491 shares of the company's stock, valued at $33,204,697.50. This trade represents a 4.94% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.60% of the stock is owned by company insiders.

BWX Technologies Company Profile

BWX Technologies, Inc NYSE: BWXT is a specialized supplier of nuclear components and services, primarily serving the U.S. government and commercial markets. The company's core expertise lies in the design, fabrication and servicing of nuclear propulsion systems for the U.S. Navy, where it supports the maintenance and overhaul of naval nuclear reactors. In addition to defense applications, BWXT develops small modular reactors (SMRs), nuclear fuel and related technologies for non‐defense power generation, offering scalable solutions to meet evolving energy and industrial demands.

Beyond propulsion and power systems, BWXT is a leading producer of medical radioisotopes used in diagnostic imaging and cancer treatment.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source